Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota

Non-alcoholic fatty liver disease (NAFLD) is a major public health problem in many countries. Berberine (BBR) is an effective therapeutic agent in alleviating NAFLD. Berberrubine (BRB) is one of the main active metabolites of BBR, which shows significant anti-obesity and antihypoglycemic effects. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sa, Cao, Shijie, Li, Congyu, Zhang, Jichao, Liu, Chang, Qiu, Feng, Kang, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304582/
https://www.ncbi.nlm.nih.gov/pubmed/35873595
http://dx.doi.org/10.3389/fphar.2022.913378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304582/
https://www.ncbi.nlm.nih.gov/pubmed/35873595
http://dx.doi.org/10.3389/fphar.2022.913378

Ejemplares similares